Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Giovanni Pappagallo

5PUBLICATIONS

27CO-AUTHORS

Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Haematology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 25, 2022

Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy.

Elena Verzoni, Giovanni Pappagallo, Filippo Alongi

|May 28, 2022

Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise.

Mirco Bartolomei, Alfredo Berruti, Massimo Falconi

|Feb 25, 2022

Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel.

Giampaolo Bianchini, Grazia Arpino, Laura Biganzoli

|Feb 15, 2022

Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus.

Antonio Coppola, Massimo Franchini, Giovanni Pappagallo

|Jun 15, 2021

The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria.

Marta Bottero, Valentina Borzillo, Stefano Pergolizzi

Pageof 1

Frequent Collaborators

1 joint publications

Marta Bottero

1 joint publications

Valentina Borzillo

1 joint publications

Stefano Pergolizzi

1 joint publications

Barbara Alicja Jereczek-Fossa

1 joint publications

Edy Ippolito

1 joint publications

Giovanni Piero Frezza

1 joint publications

Lucio Fortunato

1 joint publications

Renzo Corvò

1 joint publications

Stefano Arcangeli

1 joint publications

Stefano M Magrini

Frequent Collaborators

1 joint publications

Marta Bottero

1 joint publications

Valentina Borzillo

1 joint publications

Stefano Pergolizzi

1 joint publications

Barbara Alicja Jereczek-Fossa

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

A Practical Guide for the Production and PET/CT Imaging of <sup>68</sup>Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of <sup>68</sup>Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on : Apr 17, 2019

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

See more related videos

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

A Practical Guide for the Production and PET/CT Imaging of <sup>68</sup>Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of <sup>68</sup>Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on : Apr 17, 2019

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

See more related videos